AMGN icon

AMGN

Lightning icon

351.23 USD

-0.67%

Today

+0.94%

1D

Market is closed

Sun

Closed

Mon

3:00 AM ~ 12:00 PM

Tue

12:00 AM ~ 12:00 PM

Wed

12:00 AM ~ 12:00 PM

Thu

12:00 AM ~ 12:00 PM

Fri

12:00 AM ~ 11:00 PM

Sat

Closed

Loading chart...
1D
5D
1M
3M
1Y
MAX

Information

Name

Amgen Leveraged

Currency

USD

Standard Leverage

1X

Lightning Icon

Enhanced Leverage

3X

Lightning Icon

Overnight Fees Buy

-0.0191%

Overnight Fees Sell

0.0024%

Market Cap

190.38B

Avg Daily Volume

2.95M

52 Week High

391.29 USD

52 Week Low

261.43 USD

Trading Hours

See hours

Overnight Fees Calculator

ExposureUnits
USD
Daily Overnight Fee %Daily Overnight Fee $
BUYS-0.01910%$(0.191)
SELLS0.00240%$0.024

*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.

Business Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Top News

Weekly Buzz: MGNX Resumes LINNET; GSK Wins China Nod; FDA Okays Waters; NBIX Snaps Up SLNO

tradingview.com

23h ago

No Image

AmAirlines

-0.53%

AbbottLabs

-2.35%

Aehr.Systems

+1.44%

AmgenInc

+0.94%

Amarin

-0.91%

Apollo

-2.49%

AxonEnterprise

-1.56%

BOAmerica

-0.13%

Beyond.Inc

-1.68%

BookingHld

-1.76%

BioXcel

-0.95%

Blackstone

-1.66%

Coeur

+2.59%

CFIndustries

+1.73%

Chegg

-6.02%

Chewy

-2.86%

Clean.Spark

-2.25%

Coinbase

-1.15%

Chevron

-0.53%

Delta

-0.16%

Deere

-1.20%

DR_Horton

+0.35%

Devon

+0.23%

ElancoAnimal

-1.50%

Elevance-Health-Inc

-2.02%

Expedia

-1.01%

Freeport_Mcmoran

+2.43%

GATX_Corp

+1.37%

Greenbrier

-2.34%

GileadSci

-2.26%

GoldmanSachs

+0.80%

HimsandHers.Inc

-0.41%

Hecla.Mining

+0.73%

Humana

-2.52%

IDEXXLab

-3.76%

Insmed

-3.03%

JBHunt

+0.86%

JPMorgan

+0.09%

KKR&Co

-1.65%

Lennar

+0.51%

Levi.Strauss

+0.00%

Southwest

-1.74%

Mosaic

-2.06%

MicroStrategy

-0.76%

NorwegianCruise

+1.06%

NewmontM

+2.35%

Novavax

-5.52%

Opko

-1.74%

Occidental

+0.00%

PulteGroup

-1.54%

ProQR.Therapeutics

-6.19%

SouthernCopper

+2.32%

Scorpio.Tankers

-2.29%

TollBrothers

-0.04%

UnitySoftware

+0.33%

UnitedCon

-1.32%

UnitedHlt

-0.66%

ViaSat

+0.92%

Westinghouse

-1.21%

WellsFargo

-0.61%

ExxonMobil

-1.24%

ZoetisInc

-1.82%

BUZZ-U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg

reuters.com

2d ago

No Image

AmAirlines

-0.53%

AbbottLabs

-2.35%

Aehr.Systems

+1.44%

AmgenInc

+0.94%

Amarin

-0.91%

Apollo

-2.49%

AxonEnterprise

-1.56%

BOAmerica

-0.13%

Beyond.Inc

-1.68%

BookingHld

-1.76%

BioXcel

-0.95%

Blackstone

-1.66%

Coeur

+2.59%

CFIndustries

+1.73%

Clean.Spark

-2.25%

Coinbase

-1.15%

Chevron

-0.53%

Delta

-0.16%

Deere

-1.20%

Devon

+0.23%

ElancoAnimal

-1.50%

Elevance-Health-Inc

-2.02%

Expedia

-1.01%

Freeport_Mcmoran

+2.43%

GATX_Corp

+1.37%

Greenbrier

-2.34%

GileadSci

-2.26%

GoldmanSachs

+0.80%

Hecla.Mining

+0.73%

Humana

-2.52%

IDEXXLab

-3.76%

Insmed

-3.03%

JBHunt

+0.86%

JPMorgan

+0.09%

KKR&Co

-1.65%

Levi.Strauss

+0.00%

Southwest

-1.74%

Mosaic

-2.06%

MicroStrategy

-0.76%

NorwegianCruise

+1.06%

NewmontM

+2.35%

Novavax

-5.52%

Opko

-1.74%

Occidental

+0.00%

SouthernCopper

+2.32%

Scorpio.Tankers

-2.29%

UnitySoftware

+0.33%

UnitedCon

-1.32%

ViaSat

+0.92%

Westinghouse

-1.21%

WellsFargo

-0.61%

ExxonMobil

-1.24%

ZoetisInc

-1.82%

BUZZ-U.S. STOCKS ON THE MOVE-Delta, Levi's, banks

reuters.com

3d ago

No Image

Show more

Frequently Asked Questions

What are healthcare stocks and why are they important to investors?

Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.


Are healthcare stocks less volatile?

Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.


What drives growth in healthcare investments?

Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.


What are the risks of investing in healthcare?

Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.